Yates, Max, Hamilton, Louise E., Elender, Frances, Dean, Loretta, Doll, Helen, MacGregor, Alex J. ORCID: https://orcid.org/0000-0003-2163-2325, Thomas, Joegi and Gaffney, Karl
(2015)
Is Etanercept 25mg once weekly as effective as 50mg at maintaining response in patients with ankylosing spondylitis? A randomized control trial.
Journal of Rheumatology, 42 (7).
pp. 1177-1185.
ISSN 0315-162X
![]() |
Microsoft Word (FinalAnswersClean 10th Mar2015)
- Accepted Version
Download (73kB) |
Abstract
To investigate, in a pilot randomized controlled trial, whether etanercept (ETN) 25 mg once weekly is effective at maintaining a clinical response in patients with ankylosing spondylitis (AS) who have responded to the standard 50 mg dose.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | ankylosing spondylitis,anti-tumor necrosis factor therapy,etanercept,randomized control trial |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Medicine and Health Sciences > Allied Health Professions |
Depositing User: | Pure Connector |
Date Deposited: | 19 Aug 2015 15:16 |
Last Modified: | 21 Oct 2022 01:05 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/54126 |
DOI: | 10.3899/jrheum.141335 |
Actions (login required)
![]() |
View Item |